Browsing Tag
Australian Securities Exchange
66 posts
Capricorn Metals (ASX: CMM) jumps 14% as Mount Gibson transforms its gold growth outlook
Capricorn Metals (ASX: CMM) surged 14% after its Mount Gibson update. See how rising reserves and Range 500 reshape its gold outlook.
Integrated Research (ASX: IRI) revenue drops as Iris and Prognosis Elevate face FY2027 monetisation test
Integrated Research’s cash balance is now close to its entire ASX market value, but weaker renewals and negative EBITDA show why investors remain cautious.
Energy Action reports A$12.2m FY2026 revenue as higher costs pressure earnings
Energy Action expanded revenue and forward contracted income during FY2026, but weaker earnings expose the cost of building its energy-services platform.
Supply Network (ASX: SNL) lifts FY2026 profit 19% to A$47.7m as final dividend rises to 44c
Supply Network exceeded its annual revenue growth target and lifted profit faster than sales, but its premium ASX valuation makes continued market-share gains the next test.
Macquarie Group’s A$98bn succession bet puts Greg Ward under immediate pressure
Macquarie Group has selected long-serving banking chief Greg Ward to succeed Shemara Wikramanayake, choosing operational continuity as earnings strengthen and governance scrutiny remains elevated.
Monvia lists on ASX as MNV at A$103.5m valuation as investors test profitable insurance SaaS growth
Monvia Limited enters the Australian Securities Exchange with cash-positive operations and 121% net revenue retention, but its near-flat FY26 revenue forecast makes post-listing expansion the decisive test.
Mesoblast (ASX: MSB; Nasdaq: MESO) CEO invests A$2.73m as Ryoncil growth shifts focus to execution
Mesoblast Chief Executive Silviu Itescu has paid A$2.73 million to increase his ownership, adding an alignment signal as Ryoncil sales and late-stage programs reshape the company.
Viva Energy (ASX: VEA) shares have climbed, but the harder proof point is still ahead
Viva Energy Group’s refinery restart improved the ASX outlook, but debt, retail execution and a damaged unit make July’s update critical.
Dimerix (ASX: DXB) buys Phase 2-ready DMX-652 in deal worth up to $292m
Dimerix buys Phase 2-ready DMX-652 for US$5 million upfront, widening its kidney pipeline while taking on milestones, royalties and execution risk ahead.
Webjet Group (ASX: WJL) names Nicole Sheffield CEO as digital growth plan faces its hardest execution test
Webjet Group has recruited former Wesfarmers OneDigital executive Nicole Sheffield to lead its next growth phase, but softer bookings, margin pressure and a demanding FY27 outlook mean digital transformation must now produce measurable earnings.